These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 6199120)
1. Suppression of experimental allergic encephalomyelitis in Lewis rats treated with myelin basic protein-liposome complexes: clinical, histopathological, and cell-mediated immunity correlates. Strejan GH; Percy DH; St Louis J Cell Immunol; 1984 Mar; 84(1):171-84. PubMed ID: 6199120 [TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison. Strejan GH; St Louis J Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689 [TBL] [Abstract][Full Text] [Related]
3. Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigens. Stein CS; St Louis J; Gilbert JJ; Strejan GH J Neuroimmunol; 1990 Jul; 28(2):119-30. PubMed ID: 1694533 [TBL] [Abstract][Full Text] [Related]
4. Suppression of experimental allergic encephalomyelitis in guinea/pigs by liposome-associated human myelin basic protein. Strejan GH; Percy DH; St Louis J; Surlan D; Paty DW J Immunol; 1981 Nov; 127(5):2064-9. PubMed ID: 6170686 [TBL] [Abstract][Full Text] [Related]
5. Effect of treatment with glutaraldehyde-fixed myelin basic protein-liposomes on active induction and passive transfer of experimental allergic encephalomyelitis in Lewis rats. Strejan GH; Gilbert JJ; St Louis J Cell Immunol; 1988 Oct; 116(1):250-6. PubMed ID: 2458844 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99. Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700 [TBL] [Abstract][Full Text] [Related]
7. The role of myelin lipids in experimental allergic encephalomyelitis. III. Transfer of suppression from guinea pigs recovering from EAE, induced by myelin basic protein--galactocerebroside complexes. Hosein ZZ; Gilbert JJ; Strejan GH Cell Immunol; 1986 Apr; 99(1):265-78. PubMed ID: 2428529 [TBL] [Abstract][Full Text] [Related]
8. Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats. Pope L; Paterson PY; Miller SD J Neuroimmunol; 1992 Apr; 37(3):177-89. PubMed ID: 1373153 [TBL] [Abstract][Full Text] [Related]
9. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species. Miller A; Lider O; al-Sabbagh A; Weiner HL J Neuroimmunol; 1992 Aug; 39(3):243-50. PubMed ID: 1379607 [TBL] [Abstract][Full Text] [Related]
10. The suppression of experimental allergic encephalomyelitis in Lewis rats by treatment with myelin basic protein-cell conjugates. McKenna RM; Carter BG; Paterson JA; Sehon AH Cell Immunol; 1983 Oct; 81(2):391-402. PubMed ID: 6196127 [TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization. Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596 [TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of experimental allergic encephalomyelitis: recipient response to myelin basic protein-reactive lymphocytes. Bouwer HG; Hinrichs DJ J Neuroimmunol; 1994 Oct; 54(1-2):87-98. PubMed ID: 7523447 [TBL] [Abstract][Full Text] [Related]
13. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen. al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845 [TBL] [Abstract][Full Text] [Related]
14. Myelin-liposome protection against experimental autoimmune encephalomyelitis is associated with reduced neuroantigen-specific T-cell-mediated responses. Stein CS; St Louis J; Strejan GH Cell Immunol; 1993 Jan; 146(1):80-95. PubMed ID: 8425233 [TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of suppression of experimental allergic encephalomyelitis induced by myelin basic protein-cell conjugates. McKenna RM; Carter BG; Sehon AH Cell Immunol; 1984 Oct; 88(2):251-9. PubMed ID: 6207940 [TBL] [Abstract][Full Text] [Related]
16. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Khoury SJ; Lider O; al-Sabbagh A; Weiner HL Cell Immunol; 1990 Dec; 131(2):302-10. PubMed ID: 1700738 [TBL] [Abstract][Full Text] [Related]
17. Suppression of chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs by administration of liposome-associated myelin basic protein. Strejan GH; Gilbert JJ; St Louis J J Neuroimmunol; 1984 Nov; 7(1):27-41. PubMed ID: 6209299 [TBL] [Abstract][Full Text] [Related]
18. Antigen-driven bystander suppression after oral administration of antigens. Miller A; Lider O; Weiner HL J Exp Med; 1991 Oct; 174(4):791-8. PubMed ID: 1717632 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells. Hilliard BA; Kamoun M; Ventura E; Rostami A Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452 [TBL] [Abstract][Full Text] [Related]
20. Neurotropin inhibits experimental allergic encephalomyelitis (EAE) in Lewis rats. Naiki M; Takeoka Y; Kurimoto Y; Matsuoka T; Suehiro S; Imai Y; Osawa T; Gershwin ME Int J Immunopharmacol; 1991; 13(2-3):235-43. PubMed ID: 1712761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]